Teleflex Incorporated

Equities

TFX

US8793691069

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 16:00:01 2024-05-02 EDT 5-day change 1st Jan Change
198.7 USD -6.06% Intraday chart for Teleflex Incorporated -3.86% -20.30%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Wells Fargo Cuts Price Target on Teleflex to $210 From $265 MT
Teleflex's Fiscal Q1 Adjusted Earnings, Net Revenue Increase; Raises Low End of Fiscal 2024 Adjusted Profit Guidance MT
Transcript : Teleflex Incorporated, Q1 2024 Earnings Call, May 02, 2024
Earnings Flash (TFX) TELEFLEX INCORPORATED Posts Q1 Revenue $737.8M MT
Earnings Flash (TFX) TELEFLEX INCORPORATED Reports Q1 EPS $3.21 MT
Teleflex Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Teleflex Incorporated Raises Earnings Guidance for the Full Year 2024 CI
Teleflex Incorporated Lowers Revenue Growth Guidance for Full Year 2024 CI
Truist Securities Adjusts Teleflex Price Target to $240 From $265, Hold Rating Kept MT
Teleflex Incorporated Introduces the UroLift? 2 System with Advanced Tissue Control, A Revolutionary Unified Platform Designed to Treat All Prostate Types CI
Teleflex Gets Science Based Targets Initiative Validation For Climate Targets MT
Teleflex Insider Sold Shares Worth $1,713,825, According to a Recent SEC Filing MT
Teleflex to Seek M&A CI
Transcript : Teleflex Incorporated Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-05-2024 01:40 PM
Truist Securities Trims Price Target on Teleflex to $265 From $270, Maintains Hold Rating MT
RBC Cuts Price Target on Teleflex to $265 From $272, Keeps Outperform Rating MT
Teleflex to Seek M&A CI
Transcript : Teleflex Incorporated, Q4 2023 Earnings Call, Feb 22, 2024
Teleflex's Q4 Adjusted Earnings Fall, Revenue Rises; 2024 Guidance Issued MT
Teleflex Incorporated Announces Quarterly Dividend, Payable on March 15, 2024 CI
Earnings Flash (TFX) TELEFLEX INCORPORATED Posts Q4 Revenue $773.9M MT
Earnings Flash (TFX) TELEFLEX INCORPORATED Posts Q4 EPS $3.38 MT
Teleflex Incorporated Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Teleflex Incorporated Provides Earnings Guidance for the Year 2024 CI
MORNING BID AMERICAS-AI 'tipping point' sends Nvidia, Nasdaq, Nikkei north RE
Chart Teleflex Incorporated
More charts
Teleflex Incorporated specialises in the designing, manufacturing and selling of single-use medical devices for hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Products are sold under the brand names Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck®. Net sales break down by category of products as follows: - interventional cardiology, radiology and urology products (26.5%); - vascular access solutions (25.9%); - surgical devices (12.5%); - anesthesia products (11.9%); - other (23.2%). Net sales are distributed geographically as follows: the United States (61.8%), Europe (25.5%), Asia-Pacific (9.1%) and other (3.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
211.5 USD
Average target price
262.4 USD
Spread / Average Target
+24.05%
Consensus
  1. Stock Market
  2. Equities
  3. TFX Stock
  4. News Teleflex Incorporated
  5. Teleflex Incorporated : SVB Leerink Adjusts Price Target on Teleflex to $415 From $410, Maintains Market Perform Rating